Stroke prevention
In stroke prevention, primary prevention aims to reduce the risk of stroke in asymptomatic people and secondary stroke prevention focuses on therapies that inhibit the ability of platelets to form thromboemboli. This objective can be achieved either through direct antiplatelet action or by regulating mechanisms that affect platelet aggregation. There have been important advances in antiplatelet therapy in recent years.